531752 — Biogen Pharmachem Industries Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹619.97m
- IN₹599.81m
- 10
- 49
- 19
- 12
Annual cashflow statement for Biogen Pharmachem Industries, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -16 | -0.086 | 4.55 | 19.3 | -2.93 |
| Depreciation | |||||
| Changes in Working Capital | 55.5 | 14.1 | 12.5 | 0.138 | -7.98 |
| Change in Accounts Receivable | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 39.5 | 14 | 17 | 19.4 | -10.9 |
| Other Investing Cash Flow Items | -36.4 | -13.2 | -16.6 | -20.6 | -326 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -36.4 | -13.2 | -16.6 | -20.6 | -326 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -3.06 | 0 | 0 | 0 | 357 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.041 | 0.757 | 0.455 | -1.12 | 20 |